Acetazolamide: clinical trials recruiting now
7
Recruiting trials
10
Conditions studied
1
US states with sites
7
Countries
FDA drug label
- FDA-approved
- Yes. Acetazolamide appears in the FDA drug-label database. Marketed as acetazolamide.
- Drug class
- Carbonic Anhydrase Inhibitor (FDA established pharmacologic class)
- Mechanism of action
- Carbonic Anhydrase Inhibitors (as stated on the FDA label)
FDA-approved use
For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Acetazolamide tablets are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those who are very susceptible to acute mountain sickness despite gradual ascent.
FDA recalls / enforcement
| Reason (FDA) | Classification | Status | Initiated |
|---|---|---|---|
| Discoloration — Rubicon Research Private Limited | Class III (FDA: unlikely to cause harm) | Ongoing | 2024-08-24 |
| CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Cardinal Health Inc. | Class II (FDA: may cause temporary or reversible harm) | Terminated | 2021-03-15 |
Phase breakdown
Phase 1 1
Phase 2 2
Phase 3 1
Phase 4 2
Not applicable 2
Conditions being studied
Recruiting trials involving Acetazolamide
- Acetazolamide Per os for Decompensation of Heart Failure
- Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients
- Acetazolamide for Treatment Resistant Schizophrenia
- Add-on Diuretics in Acute Decompensated Heart Failure
- Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart Failure
- Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload
- Venous Stenting Evaluation in Patients With Intracranial Hypertension Under Long-term Acetazolamide
Common questions
Is Acetazolamide FDA-approved?
Yes, marketed as acetazolamide.
How many recruiting trials involve Acetazolamide?
7 recruiting trials across 10 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.